Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
(Insulin lispro + pramlintide) by Adocia for Obesity: Likelihood of Approval
(Insulin lispro + pramlintide) is under clinical development by Adocia and currently in Phase I for Obesity. According to GlobalData,...